CClinicalTrials.gg
RecruitingNCT06712095PILLCAMUpdated Dec 5, 2024

Video Capsule Examination in Patients With Lynch Syndrome

An interventional study of Video capsule investigation in Lynch Syndrome, Li Fraumeni Syndrome and PTEN Hamartoma Syndrome, sponsored by Royal Marsden NHS Foundation Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-05.

Sponsored by Royal Marsden NHS Foundation Trust · Not applicable, Interventional, and Diagnostic

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Surveillance for colorectal cancer (CRC) in patients predisposed to develop CRC during their lifetime has been impacted by access to colonoscopy suites and endoscopy specialists in the past couple of years. An alternative method, namely the colon capsule, has been proposed, however this investigation is time consuming for the clinician and the images require up to one hour (30-60 minutes) reading to issue a result. The investigators propose to obtain images from paired colonoscopies and colon capsules with the purpose of developing an AI algorithm which could aid the clinicians in reading the colon and expand access to this investigation.

The main aim of the study is to determine whether it is possible to obtain usable paired images from patients with Lynch and other cancer predisposition syndromes. This will depend on the willingness of the patients to take part in the study and the technical ability of obtaining data from paired images of colonoscopies and colon capsule.

At recruitment, participants will undergo a colon capsule investigation, followed by a routine colonoscopy as per their normal standard of care. Paired endoscopic images from colonoscopies and colon capsules will be collected and anonymised data will be accessed by the bioinformatician for analysis.

If the study will be successful in reaching the primary endpoint, further trials will be opened, allowing for a larger population to be included and to obtain more robust data, which eventually can lead to validated AI algorithms and application of computer-aided video-capsules examination as a screening tool in at-risk population.

02

Conditions studied

  • Lynch Syndrome
  • Li Fraumeni Syndrome
  • PTEN Hamartoma Syndrome
  • FAP
  • MUTYH Biallelic Mutation
  • STK11 Mutation
  • CDH1 Gene Mutation
  • CHEK2 Gene Mutation
  • BMPR1A Gene Mutation
  • SMAD4 Gene Mutation
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients over the age of 18 years old with no active cancer
  • No previous resection of the colon and/or rectum
  • Carriers of a pathogenic/likely pathogenic variant in any of the following cancer-predisposition genes: Lynch syndrome (MLH1, MSH2, MSH6, PMS2), APC (FAP syndrome); biallelic MUTYH; STK11 (Peutz-Jeghers syndrome); PTEN, CDH1, CHEK2, TP53, BMPR1A and SMAD4 (Juvenile polyposis syndrome)
  • Able to consent to the study and undergo colonoscopy.

Exclusion criteria

Exclusion Criteria:

  • Extensive surgery which poses a high risk of video-capsule blockage or narrowing of the bowel due to extensive tumour. Extensive surgery implies any removal of large portions of the small or large bowel that might cause a narrowing (stricture) in the digestive tract.
  • Previous irradiation to abdomen or pelvis (risk for small bowel obstruction)
  • Carriers of a variant associated with reduced penetrance (in the view of a geneticist) or a variant of uncertain significance.
  • Patients with a PS of 3 or 4 and/or mobility issues
  • Pregnancy
  • Pacemaker or internal electro-medical device (artificial heart valve, cochlear implant or an internal electromedical device).
  • Insulin-dependent diabetes
  • Patients who require deep sedation for colonoscopy
04

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
25 participants (estimated)

Study arms

  • Experimental
    Videocapsule investigation

    Device: Video capsule investigation

Interventions

  • DeviceVideo capsule investigation

    Participants will undergo both a video capsule examination and a colonoscopy on the same day.

    Also known as: Colonoscopy

05

What researchers measure

Primary outcomes

  1. The proportion of paired images the bioinformatician assesses as useful for the development of algorithm

    Time frame: 18 months

Secondary outcomes

  1. The proportion of patients at high-risk as defined by inclusion criteria who agree to undergo video capsule examination.

    Time frame: 18 months

  2. The proportion of patients who undergo both video capsule examination and colonoscopy, from whom it is possible to obtain paired images

    Time frame: 18 months

  3. The description of any adverse events collected for the Pillcam procedure.

    All adverse events will be collected using the Common Terminology Criteria for Adverse Events (CTCAE) version 5.0.

    Time frame: 18 months

06

Study locations

1 of 1 sites recruiting
  • The Royal Marsden NHS Foundation Trust
    London, (Select) SW3 6JJ, United Kingdom
    Recruiting
07

Registry details

Key details

Study ID
NCT06712095
Lead sponsor
Royal Marsden NHS Foundation Trust
Collaborators
King's College London
Responsible party
Sponsor
First posted
Dec 2, 2024
Start date
Mar 4, 2024
Primary completion
Oct 31, 2025 (estimated)
Completion
Oct 31, 2025 (estimated)
Last update
Dec 5, 2024

Study contacts

Elena Cojocaru, MD
Contact
elena.cojocaru@nhs.net
+44 20 7808 2603
Lydia Taylor, RN
Contact
lydia.taylor@rmh.nhs.uk
Richard Lee, PhD
principal investigator · Royal Marsden NHS Foundation Trust

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion